Results
eNauka >
Rezultati >
Early analysis of immunotherapy safety and benefit in metastatic/recurrent/persistent cervical cancer treated with first-line pembrolizumab: a tertiary centre experience
| Naziv: | Early analysis of immunotherapy safety and benefit in metastatic/recurrent/persistent cervical cancer treated with first-line pembrolizumab: a tertiary centre experience | Autori: | Kutic, Slobodan; Bobic, Simonida   ; Pavlovic, Lidija; Matovic, Milana ; Mijucic, Jovana; Milovic-Kovacevic, Marijana |
Godina: | 2026 | Publikacija: | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. ESGO 2026 Congress 26 February 2026 - 28 February 2026 | ISSN: | 1048-891X International Journal of Gynecological Cancer Pretraži identifikator |
Izdavač: | IGCS ESGO Wiley |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 36 br. 2 str. 103269-103269 | DOI: | 10.1016/j.ijgc.2025.103269 | WoS-ID: | 001715932700085 | URI: | https://enauka.gov.rs/handle/123456789/1035979 | URL: | https://www.international-journal-of-gynecological-cancer.com/article/S1048-891X(25)02393-X/abstract | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | Napomena o dostupnosti: | Пуни текст није јавно доступан | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.